Literature DB >> 25624724

RhoC, vascular endothelial growth factor and microvascular density in esophageal squamous cell carcinoma.

Zhi-Hua Zhao1, Yan Tian1, Jian-Pin Yang1, Jun Zhou1, Kui-Sheng Chen1.   

Abstract

AIM: To investigate the expression of Ras homolog (Rho)C, vascular endothelial growth factor (VEGF) and CD105 in esophageal squamous cell carcinoma.
METHODS: Semi-quantitative reverse transcriptase polymerase chain reaction, in situ hybridization and immunohistochemical streptavidin-biotin- peroxidase methods were used to detect expression of RhoC mRNA and protein, and VEGF protein in 62 cases with esophageal squamous cell carcinoma, 31 cases with adjacent atypical hyperplastic tissues, and 62 cases with normal esophageal mucosa. CD105 antibody labeling was used to measure microvascular density. Expression levels were compared according to clinicopathologic and patient parameters.
RESULTS: Expression of RhoC mRNA showed a positive correlation with the protein level in esophageal squamous cell carcinoma, as well as with VEGF protein levels. RhoC mRNA expression was mainly located within the cytoplasm of the tumor cells, appearing as blue to purple particles by in situ hybridization. The differences in RhoC mRNA expression in esophageal squamous cell carcinoma, adjacent atypical hyperplasia and normal esophageal mucosa were significant (P < 0.05). The relative expression of RhoC mRNA in cancer tissues with lymph node metastasis was significantly higher than in the tissues without lymph node metastasis (P < 0.05). VEGF protein expression was consistent with microvascular density (t = 25.52, P < 0.05). Positive expression of VEGF protein in esophageal squamous cell carcinoma of different histologic gradings did not differ significantly. Positive expression of VEGF protein in carcinoma tissues with deep infiltration was significantly higher than in tissues with only superficial infiltration (P < 0.05). The positive expression of VEGF protein in cancer tissues with lymph node metastasis was significantly higher than in the tissues without lymph node metastasis (P < 0.05).
CONCLUSION: RhoC protein may upregulate VEGF expression, thereby promoting tumor angiogenesis. RhoC mRNA and protein expression was correlated with metastasis.

Entities:  

Keywords:  Esophageal squamous cell carcinoma; Gene silencing; Ras homolog C; Vascular endothelial growth factor

Mesh:

Substances:

Year:  2015        PMID: 25624724      PMCID: PMC4299343          DOI: 10.3748/wjg.v21.i3.905

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  26 in total

1.  DLC-1, a Rho GTPase-activating protein with tumor suppressor function, is essential for embryonic development.

Authors:  Marian E Durkin; Miriam R Avner; Chang-Goo Huh; Bao-Zhu Yuan; Snorri S Thorgeirsson; Nicholas C Popescu
Journal:  FEBS Lett       Date:  2005-01-19       Impact factor: 4.124

2.  Vascular endothelial growth factor (VEGF) in breast cancer: comparison of plasma, serum, and tissue VEGF and microvessel density and effects of tamoxifen.

Authors:  J Adams; P J Carder; S Downey; M A Forbes; K MacLennan; V Allgar; S Kaufman; S Hallam; R Bicknell; J J Walker; F Cairnduff; P J Selby; T J Perren; M Lansdown; R E Banks
Journal:  Cancer Res       Date:  2000-06-01       Impact factor: 12.701

3.  Anti-RhoA and anti-RhoC siRNAs inhibit the proliferation and invasiveness of MDA-MB-231 breast cancer cells in vitro and in vivo.

Authors:  J-Y Pillé; C Denoyelle; J Varet; J-R Bertrand; J Soria; P Opolon; H Lu; L-L Pritchard; J-P Vannier; C Malvy; C Soria; H Li
Journal:  Mol Ther       Date:  2005-02       Impact factor: 11.454

4.  Conditional ROCK activation in vivo induces tumor cell dissemination and angiogenesis.

Authors:  Daniel R Croft; Erik Sahai; Georgia Mavria; Shuixing Li; Jeff Tsai; William M F Lee; Christopher J Marshall; Michael F Olson
Journal:  Cancer Res       Date:  2004-12-15       Impact factor: 12.701

5.  [Expressions of RhoC and osteopontin in esophageal squamous carcinoma and association with the patients' prognosis].

Authors:  Hui-zhong Zhang; Jin-geng Liu; Yi-ping Wei; Cheng Wu; Yong-ke Cao; Mei Wang
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2006-11

6.  Angiogenesis in normal tissue adjacent to colon cancer.

Authors:  S H Fox; G F Whalen; M M Sanders; J A Burleson; K Jennings; S Kurtzman; D Kreutzer
Journal:  J Surg Oncol       Date:  1998-12       Impact factor: 3.454

7.  Clinical and prognostic significance of RhoA and RhoC gene expression in esophageal squamous cell carcinoma.

Authors:  Ahmad Faried; Leri S Faried; Nurhayat Usman; Hiroyuki Kato; Hiroyuki Kuwano
Journal:  Ann Surg Oncol       Date:  2007-09-25       Impact factor: 5.344

Review 8.  Mammalian Rho GTPases: new insights into their functions from in vivo studies.

Authors:  Sarah J Heasman; Anne J Ridley
Journal:  Nat Rev Mol Cell Biol       Date:  2008-09       Impact factor: 94.444

9.  Overexpression of Rho GDP-dissociation inhibitor alpha is associated with tumor progression and poor prognosis of colorectal cancer.

Authors:  Liang Zhao; Hui Wang; Jianming Li; Yawei Liu; Yanqing Ding
Journal:  J Proteome Res       Date:  2008-07-24       Impact factor: 4.466

10.  Long-lasting complete inhibition of human solid tumors in SCID mice by targeting endothelial cells of tumor vasculature with antihuman endoglin immunotoxin.

Authors:  B K Seon; F Matsuno; Y Haruta; M Kondo; M Barcos
Journal:  Clin Cancer Res       Date:  1997-07       Impact factor: 12.531

View more
  10 in total

1.  CCR7 enhances the angiogenic capacity of esophageal squamous carcinoma cells in vitro via activation of the NF-κB/VEGF signaling pathway.

Authors:  Qing-Yong Cai; Gui-You Liang; Yi-Feng Zheng; Qun-You Tan; Ru-Wen Wang; Kun Li
Journal:  Am J Transl Res       Date:  2017-07-15       Impact factor: 4.060

2.  Regulation of CXCR4/AKT-signaling-induced cell invasion and tumor metastasis by RhoA, Rac-1, and Cdc42 in human esophageal cancer.

Authors:  Jing Guo; Xiaofang Yu; Jie Gu; Zongwu Lin; Guangyin Zhao; Fengkai Xu; Chunlai Lu; Di Ge
Journal:  Tumour Biol       Date:  2015-12-02

3.  Pathological response and serum VEGF changes during chemoradiotherapy for esophageal carcinoma.

Authors:  Jian Wang; Jing-Ping Yu; Xin-Chu Ni; Zhi-Qiang Sun; Wei Sun; Bin Nie; Su-Ping Sun; Jian-Lin Wang
Journal:  Medicine (Baltimore)       Date:  2019-05       Impact factor: 1.817

4.  Effects of RhoC downregulation on the angiogenesis characteristics of myeloma vascular endothelial cells.

Authors:  Zhihua Zhao; Kai Liu; Xiangyu Tian; Miaomiao Sun; Na Wei; Xiaoyan Zhu; Hongmei Yang; Tong Wang; Guozhong Jiang; Kuisheng Chen
Journal:  Cancer Med       Date:  2019-05-07       Impact factor: 4.452

5.  CCL3-CCR5 axis contributes to progression of esophageal squamous cell carcinoma by promoting cell migration and invasion via Akt and ERK pathways.

Authors:  Takayuki Kodama; Yu-Ichiro Koma; Noriaki Arai; Aya Kido; Naoki Urakawa; Mari Nishio; Manabu Shigeoka; Hiroshi Yokozaki
Journal:  Lab Invest       Date:  2020-05-26       Impact factor: 5.662

6.  Circular RNA AKT3 governs malignant behaviors of esophageal cancer cells by sponging miR-17-5p.

Authors:  Hong-Liang Zang; Fu-Jian Ji; Hai-Ying Ju; Xiao-Feng Tian
Journal:  World J Gastroenterol       Date:  2021-01-21       Impact factor: 5.742

7.  Role of RHOC in evaluating an adverse prognosis in patients with glioma and its potential prognostic value.

Authors:  Bo Zhang; Jiawei Yao; Xiaoyu Lian; Binfeng Liu; Yanbiao Wang; Hongbo Wang; Jialin Wang; Mengjun Zhang; Yaoye Zhao; Yongjie Zhu; Runze Liu; Yanzheng Gao
Journal:  Mol Clin Oncol       Date:  2021-06-29

8.  HOXD10 acts as a tumor-suppressive factor via inhibition of the RHOC/AKT/MAPK pathway in human cholangiocellular carcinoma.

Authors:  Haixia Yang; Jiupeng Zhou; Jianqiang Mi; Ke Ma; Yangwei Fan; Jing Ning; Chuying Wang; Xin Wei; Huadong Zhao; Enxiao Li
Journal:  Oncol Rep       Date:  2015-08-10       Impact factor: 3.906

9.  Assessing Microcirculation in Resectable Oesophageal Squamous Cell Carcinoma with Dynamic Contrast-enhanced MRI for Identifying Primary tumour and Lymphatic Metastasis.

Authors:  Yan-Li Chen; Yu Jiang; Tian-Wu Chen; Rui Li; Xiao-Ming Zhang; Fan Chen; Lan Wu; Jing Ou; Jian-Qiong Yang
Journal:  Sci Rep       Date:  2019-01-15       Impact factor: 4.379

Review 10.  The Role of Rho GTPases in VEGF Signaling in Cancer Cells.

Authors:  Nada El Baba; Mohammad Farran; Elie Abi Khalil; Leila Jaafar; Isabelle Fakhoury; Mirvat El-Sibai
Journal:  Anal Cell Pathol (Amst)       Date:  2020-04-16       Impact factor: 2.916

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.